Polypharmacy, Adverse Drug Reactions, and Geriatric Syndromes

Clinics in Geriatric Medicine

Volumn 28, Issue 2, 2012, Pages 173-186

  Shah, Bhavik M ^a   Hajjar, Emily R ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Adverse drug reactions; Elderly; Geriatric syndromes; Polypharmacy

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTACID AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ASCORBIC ACID; ATORVASTATIN; CALCIUM; CENTRAL NERVOUS SYSTEM AGENTS; CONJUGATED ESTROGEN; DIPHENHYDRAMINE; DIURETIC AGENT; GINKGO BILOBA EXTRACT; HYDROCHLOROTHIAZIDE; IBUPROFEN; LAXATIVE; LEVOTHYROXINE; LISINOPRIL; MINERAL; MULTIVITAMIN; NEUROLEPTIC AGENT; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; PSEUDOEPHEDRINE; TRANQUILIZER; UNINDEXED DRUG;

ADVERSE DRUG REACTION; AGING; COGNITIVE DEFECT; COHORT ANALYSIS; COMORBIDITY; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DELIRIUM; DRUG INDICATION; FALLING; FOOD DRUG INTERACTION; GERIATRIC DISORDER; GERIATRIC SYNDROME; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; LONGITUDINAL STUDY; MEDICATION ERROR; NUTRITIONAL STATUS; OUTPATIENT CARE; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; POLYPHARMACY; PRESCRIPTION; PREVALENCE; PUBLIC HEALTH SERVICE; RETROSPECTIVE STUDY; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SYNDROME; URINE INCONTINENCE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; AGING; DRUG INTERACTIONS; DRUG PRESCRIPTIONS; DRUG TOXICITY; FEMALE; GERIATRICS; HUMANS; MALE; PATIENT COMPLIANCE; PHARMACEUTICAL PREPARATIONS; POLYPHARMACY; PREVALENCE; RISK FACTORS;

EID: 84859710909     PISSN: 07490690     EISSN: 18798853     Source Type: Journal    
DOI: 10.1016/j.cger.2012.01.002     Document Type: Review

References (69)

1. A profile of older Americans: 2010 Administration on Aging of the United State Department of Health and Human Services, Updated February 25, 2011. Accessed August 10, 2011. http://www.aoa.gov/aoaroot/aging_statistics/Profile/2010/docs/2010profile.pdf.
2. Public health and aging: trends in aging - United States and worldwide. MMWR Morb Mortal Wkly Rep 2003, 52:101-110. Centers for Disease Control and Prevention.
3. Stewart R.B., Cooper J.W. Polypharmacy in the aged. Practical solutions. Drugs Aging 1994, 4:449-461.
4. Bikowski R., Ripsin C., Lorraine V. Physician-patient congruence regarding medication regimens. J Am Geriatr Soc 2001, 49:1353-1357.
5. Joorgensen T., Johansson S., Kennerfalk A., et al. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 2001, 35:1004-1009.
6. Linjakumpu T., Hartkainen S., Klaukka T., et al. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002, 55:809-817.
7. Fulton M.M., Allen E.R. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 2005, 17:123-132.
8. Top-line Market Data. IMS Health Web site Accessed August 18, 2011. http://www.imshealth.com/deployedfiles/ims/Global/Content/Corporate/Press%20Room/Top-line%20Market%20Data/2010%20Top-line%20Market%20Data/2010_Top_Therapeutic_Classes_by_RX.pdf.
9. Werder S.F., Preskorn S.H. Managing polypharmacy: walking a fine line between help and harm. Current Psychiatry Online 2003, 2. Accessed August 20, 2011. http://www.jfponline.com/Pages.asp?AID=601.
10. United States prescription drugs. Kaiser Family Health Foundation Accessed August 20, 2011. http://www.statehealthfacts.org/profileind.jsp?sub=66&rgn=1&cat=5.
11. Barat I., Andreasen F., Damsgaard E.M. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 2000, 56:501-509.
12. Kennerfalk A., Ruigomez A., Wallander M.A., et al. Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother 2002, 36:797-803.
13. Hajjar E.R., Cafiero A.C., Hanlon J.T. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007, 5:345-351.
14. Kaufman D., Kelly J., Rosenberg L., et al. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA 2002, 287:337-344.
15. Fialova D., Topinkova E., Gamrassi G., et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005, 293:1348-1358.
16. Nobili A., Licata G., Salerno F., et al. Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. Eur J Clin Pharmacol 2011, 67:507-519.
17. Schuler J., Dückelmann C., Beindl W., et al. Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria. Wien Klin Wochenschr 2008, 120:733-741.
18. Flaherty J.H., Perry H.M., Lynchard G.S., et al. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci 2000, 55:554-559.
19. Dwyer L.L., Han B., Woodwell D.A., et al. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey. Am J Geriatr Pharmacother 2010, 8:63-72.
20. Sloane P.D., Zimmerman S., Brown L.C., et al. Inappropriate medication prescribing in residential care/assisted living facilities. J Am Geriatr Soc 2002, 50:1001-1011.
21. Lipton H.L., Bero L.A., Bird J.A., et al. The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing. A randomized controlled trial. Med Care 1992, 30:646-658.
22. Steinman M.A., Landerfeld C.S., Rosenthal G.E., et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006, 54:1516-1523.
23. Schmader K.E., Hanlon J.T., Pieper C.F., et al. Effects of geriatric evaluation and management on adverse reactions and suboptimal prescribing in the frail elderly. Am J Med 2004, 116:394-401.
24. Hajjar E.R., Hanlon J.T., Sloane R.J., et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc 2005, 53:1518-1523.
25. Hanlon J.T., Artz M.B., Pieper C.F., et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother 2004, 38:9-14.
26. Gurwitz J.H., Field T.S., Harrold L.R., et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003, 289:1107-1116.
27. Stoehr G.P., Ganguli M., Seaberg E.C., et al. Over-the-counter medication use in an older rural community: the MoVIES project. J Am Geriatr Soc 1997, 45:158-165.
28. Bourgeois F.T., Shannon M.W., Valim C., et al. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf 2010, 19:901-910.
29. Rollason V., Vogt N. Reduction of polypharmacy in the elderly. A systematic review of the role of the pharmacist. Drugs Aging 2003, 20:817-832.
30. Hohl C.M., Dankoff J., Colacone A., et al. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001, 38:666-671.
31. Prybys K., Melville K., Hanna J., et al. Polypharmacy in the elderly: Clinical challenges in emergency practice: Part 1: Overview, etiology, and drug interactions. Emerg Med Rep 2002, 23:145-153.
32. Mallet L., Spinewine A., Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007, 370:185-191.
33. Bjorkman I.K., Fastbom J., Schmidt I.K., et al. Drug-drug interactions in the elderly. Ann Pharmacother 2002, 36:1675-1681.
34. Sloan R.W. Drug interactions. Am Fam Physician 1983, 27:229-238.
35. Juurlink D.N., Mamdani M., Kopp A., et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003, 289:1652-1658.
36. Lindblad C.I., Hanlon J.T., Gross C.R., et al. Clinically important drug-disease interactions and their prevalence in older adults. Clin Ther 2006, 28:1133-1143.
37. Lindblad C.I., Artz M.B., Pieper C.F., et al. Potential drug-disease interactions in frail, hospitalized elderly veterans. Ann Pharmacother 2005, 39:412-417.
38. Vik S.A., Maxwell C.J., Hogan D.B. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004, 38:303-312.
39. Colley C.A., Lucas L.M. Polypharmacy: the cure becomes the disease. J Gen Int Med 1993, 8:278-283.
40. Salazar J.A., Poon I., Nair M. Clinical consequences of polypharmacy in the elderly: expect the unexpected, think the unthinkable. Expert Opin Drug Saf 2007, 6:695-704.
41. Magaziner J., Cadigan D.A., Fedder D.O., et al. Medication use and functional decline among community-dwelling older women. J Aging Health 1989, 1:470-484.
42. Crenstil V., Ricks M.O., Xue Q.L., et al. A pharmacoepidemiologic study of community-dwelling, disabled older women: factors associated with medication use. Am J Geriatr Pharmacother 2010, 8:215-224.
43. Jyrkka J., Enlund H., Lavikainen P., et al. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf 2010, 20:514-522.
44. Stel V.S., Smit J.H., Plujim S.M., et al. Consequences of falling in older men and women and risk factors for health service use and functional decline. Age Aging 2004, 33:58-65.
45. Cahir C., Fahey T., Teeling M., et al. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol 2010, 69:543-552.
46. Akazawa M., Imai H., Igarashi A., et al. Potentially inappropriate medication use in elderly Japanese patients. Am J Geriatr Pharmacother 2010, 8:146-160.
47. Siddiqi N., Horne A.O., Holmes J.D. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing 2006, 35:350-364.
48. Alagiakrishnan K., Wiens C.A. An approach to drug-induced delirium in the elderly. Postgrad Med J 2004, 80:388-393.
49. Inouye S.K., Charpentier P.A. Precipitating factors for delirium in hospitalized elderly persons: predictive model and interrelationship with baseline vulnerability. JAMA 1996, 275:852-857.
50. Martin N.J., Stones M.J., Young J.E., et al. Development of delirium: a prospective cohort study in a community hospital. Int Psychogeriatr 2000, 12:117-127.
51. Hayes B.D., Klein-Schwartz W., Barrueto F. Polypharmacy and the geriatric patient. Clin Geriatr Med 2007, 23:371-390.
52. Kojima T., Akishita M., Nakamura T., et al. Association of polypharmacy with fall risk among geriatric outpatients. Geriatr Gerontol Int 2011, 11:438-444.
53. Fletcher P.C., Berg K., Dalby D.M., et al. Risk factors for falling among community-based seniors. J Patient Saf 2009, 5:61-66.
54. Tromp A.M., Plujim S.M., Smit J.H., et al. Fall-risk screening test: a positive study of predictors for falls in community-dwelling elderly. J Clin Epidemiol 2001, 54:837-844.
55. Boyle N., Naganathan V., Cumming R.G. Medication and falls: risk and optimization. Clin Geriatr Med 2010, 26:583-605.
56. Leipzig R.M., Cumming R.G., Tinetti M.E. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999, 47:30-39.
57. Leipzig R.M., Cumming R.G., Tinetti M.E. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatri Soc 1999, 47:40-50.
58. Weiner D.K., Hanlon J.T., Studenski S.A. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontol 1998, 44:217-221.
59. Kragh A., Elmstahl S., Atroshi I. Older adults medication use 6 months before and after hip fracture: A population-based cohort study. J Am Geriatr Soc 2011, 58:863-868.
60. Gormely E.A., Griffiths D.J., McCracken P.N., et al. Polypharmacy and its effect of urinary incontinence in a geriatric population. Br J Urol 1993, 71:265-269.
61. Ruby C.M., Hanlon J.T., Fillenbaum G.G., et al. Medication use and control of urination among community-dwelling older adults. J Aging Health 2005, 17:661-674.
62. Heuberger R.A., Caudell K. Polypharmacy and nutritional status in older adults. Drugs Aging 2011, 28:315-323.
63. Muir A.J., Sanders L.L., Wilkinson W.E., et al. Reducing medication regimen complexity. A controlled trial. J Gen Intern Med 2004, 16:77-82.
64. Zarowitz B.J., Stebelsky L.A., Muma B.K., et al. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy 2005, 25:1636-1645.
65. Hanlon J.T., Weinberger M., Samsa G.P., et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996, 100:428-437.
66. Galt K.A. Cost avoidance, acceptance, and outcomes associated with a pharmacotherapy consult clinic in a Veterans Affairs Medical Center. Pharmacotherapy 1998, 18:1103-1111.
67. Fillit H.M., Futterman R., Orland B.I., et al. Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews. Am J Manag Care 1999, 5:587-594.
68. Fick D.M., Maclean J.R., Rodriguez N.A., et al. A randomized study to decrease the use of potentially inappropriate medications among community-dwelling older adults in a southeastern managed care organization. Am J Manag Care 2004, 10:761-768.
69. Schrader S.L., Dressing B., Blue R., et al. The medication reduction project: combating polypharmacy in South Dakota elders through community-based interventions. S D J Med 1996, 49:441-448.